文献速递细菌感染、耐药与抗菌药物

纸片扩散法、Sensititre EUMDROXF 微孔板与 MTS 梯度条检测多重耐药铜绿假单胞菌对头孢地尔敏感性的性能评价

Performance of discs, sensititre EUMDROXF microplates and MTS gradient strips for the determination of the susceptibility of multidrug-resistant Pseudomonas aeruginosa to cefiderocol.
PubMed 文献 · Clin Microbiol Infect · 2022-12-29

该研究纳入2015至2022年分离的150株对头孢他啶、亚胺培南和头孢洛扎/他唑巴坦耐药的多重耐药铜绿假单胞菌临床株,平行采用纸片扩散法、Sensititre EUMDROXF微孔板和MTS梯度条测定头孢地尔敏感性,并与肉汤微量稀释参考法比较。结果显示参考法MIC50和MIC90分别为1 mg/L和8 mg/L,耐药株占21.3%(32/150),所有方法均未达到可接受标准,Sensititre EUMDROXF微孔板可替代参考法但折点附近需参考法确认,MTS梯度条不鼓励使用。

要点

  • 参考法测得头孢地尔MIC50为1 mg/L、MIC90为8 mg/L,耐药株占21.3%(32/150)。
  • Sensititre EUMDROXF微孔板高估MIC值,分类一致率为86.7%(130/150)。
  • MTS梯度条低估MIC值,仅正确识别50%(16/32)的耐药株。

核心结论

  • Sensititre EUMDROXF微孔板可作为参考肉汤微量稀释法检测多重耐药铜绿假单胞菌对头孢地尔敏感性的替代方法。
  • 当MIC值与折点(2 mg/L)相差±1个稀释度时,应以肉汤微量稀释法进行确认。
  • 不鼓励使用MTS梯度条;纸片扩散法可能有助于筛查,但许多头孢地尔耐药株未被检出。

研究设计与样本

  • 研究纳入2015至2022年分离的150株对头孢他啶(MIC>8 mg/L)、亚胺培南(MIC>4 mg/L)和头孢洛扎/他唑巴坦(MIC>4/4 mg/L)耐药的多重耐药铜绿假单胞菌临床株。
  • 平行采用纸片扩散法(Mast、Oxoid和Liofilchem纸片置于Bio-Rad、BioMérieux、Mast、Becton Dickinson、I2A和Oxoid的Mueller-Hinton琼脂批次上)、MTS梯度条(Liofilchem)和Sensititre EUMDROXF微孔板测定头孢地尔敏感性。
  • 将MIC值和抑菌圈直径与肉汤微量稀释参考法的MIC值进行比较,可接受标准为基本一致率(EA)≥90%且偏倚=±30%。

主要发现

  • 参考法测得头孢地尔MIC50为1 mg/L、MIC90为8 mg/L,耐药株占21.3%(32/150)。
  • 所有方法均未达到可接受标准(EA≥90%;偏倚=±30%)。
  • Sensititre EUMDROXF微孔板高估MIC值,分类一致率(CA)为86.7%(130/150,95%CI 80.3-91.2),EA为69.3%(104/150,95%CI 61.6-76.2),偏倚为68.2%。
  • MTS梯度条低估MIC值,CA为86.7%(130/150,95%CI 80.3-91.2),EA为69.3%(104/150,95%CI 61.6-76.2),偏倚为-30.4%,仅正确分类50%(16/32)的耐药株。
  • 纸片扩散法未能检出许多头孢地尔耐药株,不同Mueller-Hinton琼脂批次的CA范围为78.0%(117/150,95%CI 70.7-83.0)至89.3%(134/150,95%CI 83.4-93.3)。

关键数值与推荐

  • 可接受标准:基本一致率(EA)≥90%;偏倚=±30%。
  • 头孢地尔折点为2 mg/L;MIC值与折点相差±1个稀释度时应以肉汤微量稀释法确认。

临床怎么用

  • 作者认为Sensititre EUMDROXF微孔板可作为参考肉汤微量稀释法的替代方法。
  • 作者建议当MIC值与折点(2 mg/L)相差±1个稀释度时,应以肉汤微量稀释法进行确认。
  • 作者不鼓励使用MTS梯度条;纸片扩散法可能有助于筛查,但许多头孢地尔耐药株未被检出。

局限性

  • 所有方法均未达到可接受标准(EA≥90%;偏倚=±30%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To evaluate the performance of commercially available tests to determine the susceptibility of multidrug-resistant (MDR) clinical Pseudomonas aeruginosa strains to cefiderocol. METHODS: A collection of 150 clinical strains of P. aeruginosa resistant to ceftazidime, (MIC, Minimal Inhibitory Concentration, MIC > 8 mg/L) imipenem (MIC> 4 mg/L) and ceftolozane/tazobactam (MIC> 4/4 mg/L), isolated from 2015 to 2022 was selected. Cefiderocol susceptibility was determined in parallel (a) by disc diffusion using Mast, Oxoid and Liofilchem discs deposited on Mueller-Hinton agar batches from Bio-Rad, BioMérieux, Mast, Becton Dickinson, I2A and Oxoid; (b) by MIC gradient test strips (MTS) (Liofilchem); and (c) by EUMDROXF Sensititre microplates. MICs and inhibition zones were compared with the broth microdilution reference method (BMD) MICs. RESULTS: The MIC50 and MIC90 of cefiderocol were 1 mg/L and 8 mg/L by BMD, respectively, including 21.3% (32/150) resistant strains. None of the methods tested fulfilled acceptable criteria (essential agreement [EA] ≥ 90%; bias = ± 30%). Although the Sensititre EUMDROXF microplates overestimated MIC values (categorical agreement [CA] = 86.7% [130/150, 95% CI 80.3-91.2]; EA = 69.3% [104/150, 95% CI 61.6-76.2]; bias = 68.2%), MTS strips underestimated the MIC values for many strains (CA = 86.7%, 130/150, 95% CI 80.3-91.2; EA = 69.3%, 104/150, 95% CI 61.6-76.2; bias = -30.4%), classifying properly only 50% (16/32) of resistant strains. Finally, many cefiderocol-resistant strains were not identified by the disc method, although the CA ranged from 78.0% (117/150, 95% CI 70.7-83.0) to 89.3% (134/150, 95% IC 83.4-93.3) according to Mueller-Hinton agar batches. CONCLUSION: Determination of cefiderocol susceptibility in MDR P. aeruginosa clinical strains by Sensititre EUMDROXF microplates is an alternative to the reference BMD method. However, MIC values ± 1 dilution apart from the breakpoint (2 mg/L) should be controlled by BMD whereas the use of MTS gradient strips is discouraged. Disc diffusion might be useful for screening, unfortunately many cefiderocol-resistant strains are not detected.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Devoos L, Biguenet A, Rousselot J, et al. Performance of discs, sensititre EUMDROXF microplates and MTS gradient strips for the determination of the susceptibility of multidrug-resistant Pseudomonas aeruginosa to cefiderocol. Clin Microbiol Infect. 2022. PMID: 36587736. doi:10.1016/j.cmi.2022.12.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。